CLYM(Climb Bio, Inc.) · 内部人交易

CLYM(Climb Bio, Inc.) 的内部人交易:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。

CLYM 最近的内部人买卖(Form 4)
交易日姓名职务类型股数价格
2026-09-15Thomas Stephen Basil董事公开市场卖出100,000$13.67
2026-06-29Brennan AoifePresident and CEO公开市场卖出30,902$13.17
2026-02-26Thomas Stephen Basil董事公开市场卖出16,313$7.01
2026-02-25Thomas Stephen Basil董事公开市场卖出33,687$7.00
2026-02-13Thomas Stephen Basil董事公开市场卖出10,000$5.81
2026-02-12Thomas Stephen Basil董事公开市场卖出90,000$5.23
2026-01-05RA CAPITAL MANAGEMENT, L.P.董事、10% 股东公开市场买入7,111$3.50
2025-12-12RA CAPITAL MANAGEMENT, L.P.董事、10% 股东公开市场买入101,462$2.86
2025-12-11RA CAPITAL MANAGEMENT, L.P.董事、10% 股东公开市场买入213,099$2.18
2025-06-30Brennan AoifePresident and CEO公开市场卖出20,618$1.22
2025-06-20Pimblett EmilySVP, Finance & CAO公开市场卖出1,242$1.24
2025-03-20Pimblett EmilySVP, Finance & CAO公开市场卖出1,199$1.31
2024-12-19Pimblett EmilyCHIEF ACCOUNTING OFFICER公开市场卖出1,235$2.02

Climb Bio, Inc. CLYM